HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.

Abstract
Glycation has been implicated in the endothelial dysfunction that contributes to both diabetes- and aging-associated vascular complications. The aim of the present study was to determine whether Amadori-glycated phosphatidylethanolamine (Amadori-PE), a lipid-linked glycation compound that is formed at an increased rate in hyperglycemic states, affected proliferation, migration and tube formation of cultured human umbilical vein endothelial cells (HUVEC). Amadori-PE at a low concentration of less than 5 microM significantly enhanced these three factors involved in angiogenesis. Furthermore, stimulation of HUVEC with Amadori-PE resulted in secretion of matrix metalloproteinase 2 (MMP-2), a pivotal enzyme in the initial step of angiogenesis. Our results demonstrated for the first time that Amadori-PE may be an important compound that promotes vascular disease as a result of its angiogenic activity on endothelial cells. We also demonstrated that MMP-2 is a primary mediator of Amadori-PE-driven angiogenesis.
AuthorsJeong-Ho Oak, Kiyotaka Nakagawa, Shinichi Oikawa, Teruo Miyazawa
JournalFEBS letters (FEBS Lett) Vol. 555 Issue 2 Pg. 419-23 (Dec 04 2003) ISSN: 0014-5793 [Print] England
PMID14644453 (Publication Type: Journal Article)
Chemical References
  • Phosphatidylethanolamines
  • Vascular Endothelial Growth Factors
  • Collagenases
Topics
  • Cell Division (drug effects)
  • Cell Movement (drug effects)
  • Cells, Cultured
  • Collagenases (metabolism)
  • Endothelium, Vascular (cytology, drug effects, metabolism)
  • Fibroblasts (drug effects, metabolism)
  • Glycosylation
  • Humans
  • Neovascularization, Pathologic (drug therapy)
  • Phosphatidylethanolamines (chemistry, pharmacology)
  • Umbilical Veins (cytology)
  • Vascular Endothelial Growth Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: